Stay awhile

Log In | Sign Up



Carl Zeiss Meditec

Selected Articles

2025-08-10
Yahoo Entertainment
Carl Zeiss Meditec AG Just Missed EPS By 28%: Here's What Analysts Think Will Happen Next
2025-08-08
Thefly.com
Carl Zeiss Meditec price target lowered by EUR 5.90 at JPMorgan
2025-08-08
GlobeNewswire
Spectacle Lens Market Poised for Growth, Expected to Reach USD 78.91 Billion by 2032 - Coherent Market Insights
2025-07-22
Antaranews.com
ZEISS Group Appoints Martin Fischer as President and CEO of ZEISS Greater China
2025-07-18
GlobeNewswire
Ophthalmics Collaboration and Licensing Deals Report and Directory 2025 | Company A-Z, Therapy Focus, Upfront, Milestone, Royalties
2025-07-12
ETF Daily News
Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Down 1.9% – Here's Why
2025-07-08
GlobeNewswire
Optical Imaging Market to Reach USD 5.30 Billion by 2032, Fueled by Rising Demand for Non-Invasive Diagnostic Technologies and OCT-Driven Clinical Expansion – SNS Insider
2025-06-20
ETF Daily News
Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Down 1.3% – Here's Why
2025-06-18
The BMJ
Photoreceptor cone loss is associated with decreased deep retinal vessel density and impaired retinal sensitivity in high myopia
2025-05-29
GlobeNewswire
Radiotherapy Devices Market Opportunities and Strategies Report 2025-2033: External Beam Radiation Therapy Devices Dominate, Oncological Treatment Centers to Drive Future Growth

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG. DE0005313704 www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir